Last Build Date: Thu, 27 Apr 2017 13:15:00 -0400
Thu, 27 Apr 2017 13:15:00 -0400Exposure to these medicines for lengthy periods of time or over multiple surgeries or procedures may negatively affect brain development in children younger than 3 years.
Tue, 25 Apr 2017 09:25:00 -0400Use of unproven or unapproved products may be unsafe and could prevent a person from seeking an appropriate and potentially life-saving cancer diagnosis or treatment.
Mon, 24 Apr 2017 10:05:00 -0400Particulate administered to a patient could result in local swelling, irritation of blood vessels or tissue, blockage of blood vessels and/or systemic allergic response to the particulate.
Fri, 21 Apr 2017 14:10:00 -0400Mislabeled product could expose the consumer or their pet(s) to potential overdosing that can cause severe intoxication which may lead to cardiogenic shock, renal failure, coma or death.
Thu, 20 Apr 2017 11:30:00 -0400New and strengthened WARNINGS and CONTRAINDICATIONS on drug labels describing serious risks, including slowed or difficult breathing and death.
Wed, 19 Apr 2017 08:55:00 -0400Use of these products may pose a threat to consumers because the undeclared ingredients may interact with nitrates found in some prescription drugs and may lower blood pressure to dangerous levels.
Thu, 13 Apr 2017 19:00:00 -0400Updated 04/13/2017. Homeopathic teething products containing belladonna pose an unnecessary risk to infants and children.
Sat, 08 Apr 2017 21:29:00 -0400If left untreated, under-drainage can potentially lead to coma and death.
Thu, 06 Apr 2017 16:35:00 -0400Voluntary recall of all lots of sterile products, to the hospital/user level.
Wed, 05 Apr 2017 13:40:00 -0400Potential for ventilator reset during normal operation, without an accompanying alarm.
Fri, 31 Mar 2017 19:00:00 -0400Failure to activate or increased force needed to activate may have significant health consequences for a patient experiencing a life-threatening allergic reaction (anaphylaxis).
Fri, 31 Mar 2017 13:30:00 -0400Tip could enter the patient's bloodstream, resulting in prolonged procedure times, additional surgery to remove the tip from the patient, blood clots, internal tears and perforation to arteries or veins, excessive bleeding, and death.
Thu, 30 Mar 2017 09:50:00 -0400Sibutramine may substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.
Fri, 24 Mar 2017 13:20:00 -0400A delay in delivering therapy could result in serious patient injury such as permanent organ damage, brain injury, or death.
Tue, 21 Mar 2017 13:00:00 -0400BIA-ALCL is a rare condition; when it occurs, it has been identified most frequently in patients undergoing implant revision operations for late onset, persistent seroma.
Sat, 18 Mar 2017 10:00:00 -0400Increased rate of major adverse cardiac events observed in patients receiving the BVS, when compared to patients treated with metallic XIENCE drug-eluting stent.
Wed, 15 Mar 2017 12:02:00 -0400Patients who do not have a gallbladder should not take Viberzi. Developing pancreatitis could result in hospitalization or death.
Tue, 14 Mar 2017 13:20:00 -0400Patients may receive a drug overdose or under dose which can lead to serious adverse health consequences such as respiratory depression, coma or death.
Thu, 09 Mar 2017 14:23:00 -0500Device has shut down unexpectedly during patient treatment, which may expose patients to the risk of serious harm or death. Posted 01/14/2017
Thu, 09 Mar 2017 13:40:00 -0500Nationwide recall of Regeneca's entire line of herbal and dietary supplement products.